Anagenex is building a novel platform for drug discovery focusing on difficult targets.

Anagenex's technology analyzes 100-1000x more compounds compared to traditional approaches by combining machine learning with DNA Encoded Libraries.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2019

• Founders

  • Nicolas Tilmans, PhD
  • Zavain Dar

  LUX Partners

  • Zavain Dar

• Latest Tweets

  • We've had a wonderful partnership with Benchling from day 0 because for us, every datapoint is one step closer to a… https://t.co/oC5kdcY4bM@anagenex - 06:37 PM Jul 26th
  • Congrats to the @zebi_ai team, excited that @Relay_Tx values massively parallel data generation and sees what it ca… https://t.co/nnJgE2Pn1D@anagenex - 10:08 PM Apr 16th
  • Welcome @henripal to the team! Henri is a fantastic ML Engineer with a deep understanding of biochemistry and machi… https://t.co/SXGYmaLprm@anagenex - 05:32 PM Dec 11th